Tips on How to Stop Taking Lexapro. Lexapro, the brand name of a prescription selective serotonin reuptake inhibitor, or SSRI is used to treat depression and anxiety. Lexapro, like any SSRI medication, can cause serious withdrawal effects when discontinuing the medication too abruptly. People wishing to stop taking Lexapro should follow a specific process to reduce or eliminate the likelihood of these withdrawal effects. Get approval from a doctor. Sometimes people want to stop taking the medication as soon as they feel better, but doing so without the approval of a doctor may be dangerous. People discontinuing Lexapro need to wean off the medication gradually under the supervision of a doctor. Discuss the weaning process with a doctor. The doctor will be able to explain in detail the possible effects of Lexapro withdrawal, which commonly include irritability, dizziness, anxiety, headaches, insomnia, agitation, tiredness, confusion and a burning or tingling sensation, explains the health website e. Med. TV. com. Decrease the amount of Lexapro taken by carefully following your doctor's instructions. Although it may be tempting to expedite the weaning process by lowering the dosage more than recommended or stopping the medication entirely, doing so will increase the likelihood of withdrawal symptoms and may be dangerous. ![]() Report any troublesome withdrawal effects to your doctor. While most people will experience only mild withdrawal effects when following a doctor's recommended weaning plan, some people will experience severe or bothersome effects. If this is the case, ask your doctor if a different weaning plan would be more appropriate. The doctor may prescribie the original dosage again before implementing the new weaning plan or may continue at the current dosage but at a more gradual rate, explains the medication website Rx. FDA prescribing information, side effects and uses. Schizophrenia. Oral Zyprexa is indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6- week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 1. Clinicians should consider the potential long- term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents . Efficacy was established in three clinical trials in adult patients with manic or mixed episodes of bipolar I disorder: two 3- to 4- week trials and one monotherapy maintenance trial. ![]() ![]() ![]() She specializes in the. In adolescent patients with manic or mixed episodes associated with bipolar I disorder (ages 1. Clinicians should consider the potential long- term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents . Efficacy was established in two 6- week clinical trials in adults. ![]() The effectiveness of adjunctive therapy for longer- term use has not been systematically evaluated in controlled trials . For pediatric schizophrenia, symptom profiles can be variable, and for bipolar I disorder, pediatric patients may have variable patterns of periodicity of manic or mixed symptoms. It is recommended that medication therapy for pediatric schizophrenia and bipolar I disorder be initiated only after a thorough diagnostic evaluation has been performed and careful consideration given to the risks associated with medication treatment. Medication treatment for both pediatric schizophrenia and bipolar I disorder should be part of a total treatment program that often includes psychological, educational and social interventions. Zyprexa Intra. Muscular: Agitation Associated with Schizophrenia and Bipolar I Mania. Zyprexa Intra. Muscular is indicated for the treatment of acute agitation associated with schizophrenia and bipolar I mania. Efficacy was demonstrated in 3 short- term (2. IM treatment) placebo- controlled trials in agitated adult inpatients with: schizophrenia or bipolar I disorder (manic or mixed episodes) . When using Zyprexa and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax. Zyprexa monotherapy is not indicated for the treatment of depressive episodes associated with bipolar I disorder. ![]() Zyprexa and Fluoxetine in Combination: Treatment Resistant Depression. Oral Zyprexa and fluoxetine in combination is indicated for the treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode), based on clinical studies in adult patients. When using Zyprexa and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax. Zyprexa monotherapy is not indicated for the treatment of treatment resistant depression. Zyprexa Dosage and Administration. Schizophrenia. Adults. Dose Selection — Oral olanzapine should be administered on a once- a- day schedule without regard to meals, generally beginning with 5 to 1. Further dosage adjustments, if indicated, should generally occur at intervals of not less than 1 week, since steady state for olanzapine would not be achieved for approximately 1 week in the typical patient. When dosage adjustments are necessary, dose increments/decrements of 5 mg QD are recommended. Efficacy in schizophrenia was demonstrated in a dose range of 1. However, doses above 1. An increase to a dose greater than the target dose of 1. Olanzapine is not indicated for use in doses above 2. Find patient medical information for Zyprexa Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Pancreatitis occurs when digestive enzymes become activated while still in the pancreas, irritating the cells of your pancreas and causing inflammation. Photo Credit Hemera Technologies/AbleStock.com/Getty Images. Not all kidney stones are made up of the same crystals. The different types of kidney stones include: Calcium. Calcium stones are the most common. Do you feel like you're too thin? If so, you'll need to increase your caloric intake if you want to gain weight. That seems easy enough, but not if you're too busy to. In an infectious disease, the incubation period is the time between infection and the appearance of symptoms. The latency period is the time between infection and the. Dosing in Special Populations — The recommended starting dose is 5 mg in patients who are debilitated, who have a predisposition to hypotensive reactions, who otherwise exhibit a combination of factors that may result in slower metabolism of olanzapine (e. When indicated, dose escalation should be performed with caution in these patients. ![]() ![]() ![]() ![]() Maintenance Treatment — The effectiveness of oral olanzapine, 1. Zyprexa for approximately 8 weeks and were then followed for relapse has been demonstrated in a placebo- controlled trial . The physician who elects to use Zyprexa for extended periods should periodically reevaluate the long- term usefulness of the drug for the individual patient. Adolescents. Dose Selection — Oral olanzapine should be administered on a once- a- day schedule without regard to meals with a recommended starting dose of 2. Efficacy in adolescents with schizophrenia was demonstrated based on a flexible dose range of 2. When dosage adjustments are necessary, dose increments/decrements of 2. The safety and effectiveness of doses above 2. Thus, it is generally recommended that responding patients be continued beyond the acute response, but at the lowest dose needed to maintain remission. Patients should be periodically reassessed to determine the need for maintenance treatment. Bipolar I Disorder (Manic or Mixed Episodes)Adults. Dose Selection for Monotherapy — Oral olanzapine should be administered on a once- a- day schedule without regard to meals, generally beginning with 1. Dosage adjustments, if indicated, should generally occur at intervals of not less than 2. When dosage adjustments are necessary, dose increments/decrements of 5 mg QD are recommended. Short- term (3- 4 weeks) antimanic efficacy was demonstrated in a dose range of 5 mg to 2. The safety of doses above 2. The physician who elects to use Zyprexa for extended periods should periodically reevaluate the long- term usefulness of the drug for the individual patient. Dose Selection for Adjunctive Treatment — When administered as adjunctive treatment to lithium or valproate, oral olanzapine dosing should generally begin with 1. Antimanic efficacy was demonstrated in a dose range of 5 mg to 2. The safety of doses above 2. Adolescents. Dose Selection — Oral olanzapine should be administered on a once- a- day schedule without regard to meals with a recommended starting dose of 2. Efficacy in adolescents with bipolar I disorder (manic or mixed episodes) was demonstrated based on a flexible dose range of 2. When dosage adjustments are necessary, dose increments/decrements of 2. The safety and effectiveness of doses above 2. Thus, it is generally recommended that responding patients be continued beyond the acute response, but at the lowest dose needed to maintain remission. Patients should be periodically reassessed to determine the need for maintenance treatment. Administration of Zyprexa ZYDIS (olanzapine orally disintegrating tablets)After opening sachet, peel back foil on blister. Do not push tablet through foil. Immediately upon opening the blister, using dry hands, remove tablet and place entire Zyprexa ZYDIS in the mouth. Tablet disintegration occurs rapidly in saliva so it can be easily swallowed with or without liquid. Zyprexa Intra. Muscular: Agitation Associated with Schizophrenia and Bipolar I Mania. Dose Selection for Agitated Adult Patients with Schizophrenia and Bipolar I Mania — The efficacy of intramuscular olanzapine for injection in controlling agitation in these disorders was demonstrated in a dose range of 2. The recommended dose in these patients is 1. A lower dose of 5 or 7. If agitation warranting additional intramuscular doses persists following the initial dose, subsequent doses up to 1. However, the efficacy of repeated doses of intramuscular olanzapine for injection in agitated patients has not been systematically evaluated in controlled clinical trials. Also, the safety of total daily doses greater than 3. Maximal dosing of intramuscular olanzapine (e. Thus, it is recommended that patients requiring subsequent intramuscular injections be assessed for orthostatic hypotension prior to the administration of any subsequent doses of intramuscular olanzapine for injection. The administration of an additional dose to a patient with a clinically significant postural change in systolic blood pressure is not recommended. If ongoing olanzapine therapy is clinically indicated, oral olanzapine may be initiated in a range of 5- 2. A lower dose of 2. Do not administer intravenously or subcutaneously. Inject slowly, deep into the muscle mass. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Directions for Preparation of Zyprexa Intra. Muscular with Sterile Water for Injection — Dissolve the contents of the vial using 2. L of Sterile Water for Injection to provide a solution containing approximately 5 mg/m. L of olanzapine. The resulting solution should appear clear and yellow. Zyprexa Intra. Muscular reconstituted with Sterile Water for Injection should be used immediately (within 1 hour) after reconstitution. Discard any unused portion. The following table provides injection volumes for delivering various doses of intramuscular olanzapine for injection reconstituted with Sterile Water for Injection. Dose, mg Olanzapine. Volume of Injection, m. L1. 0Withdraw total contents of vial. Physical Incompatibility Information — Zyprexa Intra. Muscular should be reconstituted only with Sterile Water for Injection. Zyprexa Intra. Muscular should not be combined in a syringe with diazepam injection because precipitation occurs when these products are mixed. Lorazepam injection should not be used to reconstitute Zyprexa Intra. Muscular as this combination results in a delayed reconstitution time. Zyprexa Intra. Muscular should not be combined in a syringe with haloperidol injection because the resulting low p. H has been shown to degrade olanzapine over time. Zyprexa and Fluoxetine in Combination: Depressive Episodes Associated with Bipolar I Disorder. When using Zyprexa and fluoxetine in combination, also refer to the Clinical Studies section of the package insert for Symbyax.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |